by The Scientist –
Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver exogenous bone marrow stem cells into patients, which may trigger body repair machinery or regulate the endogenous stem cell population to achieve tissue homeostasis and regeneration. Cell-based therapies provide hope for patients suffering from many diseases, including immune system disorders, cancer, congenital thrombocytopenia, and sickle cell anemia, where conventional treatments fail to provide favorable outcomes.
In this Innovation Spotlight, Kevin Caldwell, chief executive officer, co-founder, and president of Ossium Health, discusses how Ossium’s bone marrow banking platform offers a streamlined stem cell transplant process, enabling patients to undergo treatment much faster than previously possible.
